JAIME GISH: Open Payments
NPI 1932598117 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$640 in 43 payments from 10 companies in 2025. Trend: 2023 $639 · 2024 $731 · 2025 $640
Food & beverage: $597Education: $43
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $237 |
| Hill Dermaceuticals, Inc. | 2 | $90 |
| UCB, Inc. | 4 | $79 |
| ABBVIE INC. | 4 | $69 |
| Novartis Pharmaceuticals Corporation | 4 | $59 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 2 | $29 |
| PFIZER INC. | 1 | $15 |
| Organogenesis Inc. | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: TREMFYA, Tolak, Bimzelx, COSENTYX, RINVOQ, Sotyktu, DUPIXENT, SKYRIZI.
Industry payments across KY — which companies pay providers there.
